Reverse Vaccinology Approach to Potential Vaccine Candidates Against Acinetobacter baumannii

Methods in Molecular Biology
Fatima ShahidAmjad Ali

Abstract

Acinetobacter baumannii is a rapidly evolving pathogen that largely inhabits intensive care units (ICU). This opportunistic, gram-negative organism has shown noteworthy taxonomic variations during the past three decades. A. baumannii functions as a catalase-positive, oxidase-negative obligate, aerobic, nonmotile, highly infectious, and multidrug-resistant bacterium. Therefore, the infection caused by this bacterium tends to have a fairly higher incidence rate in immune-compromised individuals ranging from 26.5% to 91%, as it colonizes in skin tissues and secretions of the respiratory tract. Recently, it has been globally labeled as a "red alert" pathogen, setting alarms throughout the medical community, arising mainly due to its widespread antibiotic resistance continuum. There is a dire need for alternative therapeutic intervention to combat A. baumannii-associated infections and the growing resistance. This chapter focuses upon the reverse vaccinology-based steps and strategies to identify novel potential vaccine candidates against this emerging pathogen.

Citations

Dec 4, 2019·Medical Microbiology and Immunology·Arno ThibauVolkhard A J Kempf
Dec 9, 2020·FEMS Microbiology Reviews·Mireia López-SilesMichael J McConnell
Feb 9, 2021·Expert Review of Vaccines·Crystal Ma, Wangxue Chen
May 4, 2021·Frontiers in Immunology·Michael J McConnell, Antonio J Martín-Galiano
May 7, 2021·FEMS Microbiology Reviews·Mireia López-SilesMichael J McConnell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.